Home
Corporate
Board of Directors
Company Overview
Corporate Governance
Our Investors
Annual and Interim Reports
Share Price Information
ASX Announcements
Top 20 Shareholders
Disclaimer
Contact Us
Acuvax Limited
Acuvax Ltd (ASX: ACU) remains involved in research and development. The company is currently assessing the most promising areas of diagnostic and therapeutic research within which it will seek to operate.
Latest Announcements
2012-01-25
Proposed Diagnostic Technology Acquisition
View PDF
2011-11-25
Results of AGM and New Constitution
View PDF
2011-10-14
Annual Report for year ended 30 June 2011
View PDF
2011-10-14
AGM Notice of Meeting
View PDF
Share Price